KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for LifeMD (LFMD) over the last 10 years, with Q3 2025 value amounting to $262747.0.

  • LifeMD's Depreciation & Amortization (CF) rose 7362.29% to $262747.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 3057.59%. This contributed to the annual value of $6.2 million for FY2024, which is 4418.6% up from last year.
  • Latest data reveals that LifeMD reported Depreciation & Amortization (CF) of $262747.0 as of Q3 2025, which was up 7362.29% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Depreciation & Amortization (CF) registered a high of $1.8 million during Q2 2025, and its lowest value of $10695.0 during Q4 2021.
  • In the last 5 years, LifeMD's Depreciation & Amortization (CF) had a median value of $53759.0 in 2023 and averaged $453555.6.
  • Per our database at Business Quant, LifeMD's Depreciation & Amortization (CF) soared by 1391.88% in 2023 and then skyrocketed by 297484.16% in 2024.
  • LifeMD's Depreciation & Amortization (CF) (Quarter) stood at $10695.0 in 2021, then skyrocketed by 319.61% to $44877.0 in 2022, then increased by 28.5% to $57666.0 in 2023, then soared by 188.35% to $166278.0 in 2024, then soared by 58.02% to $262747.0 in 2025.
  • Its last three reported values are $262747.0 in Q3 2025, $1.8 million for Q2 2025, and $1.7 million during Q1 2025.